|
Development of Severe Anemia and Changes in Hemoglobin in a
Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and
Tenofovir-Containing Antiretroviral Regimens.
Parkes-Ratanshi R, Katende D, et al
J Int Assoc Provid AIDS Care.
2014
Nov 25
Abstract
Peripheral Blood Mitochondrial DNA/Nuclear DNA (mtDNA/nDNA) Ratio
as a Marker of Mitochondrial Toxicities of Stavudine Containing Antiretroviral
Therapy in HIV-Infected Malawian Patients.
Kampira E, Dzobo K, Kumwenda J,
et al
OMICS. 2014 May 9.
Abstract
Longitudinal lactate levels from routine point-of-care monitoring in adult
Malawian antiretroviral therapy patients: associations with stavudine
toxicities.
Chagoma N, Mallewa J, Kaunda S,
et
al
Trans R Soc Trop Med Hyg.
2013 Aug
Abstract
The early effects of stavudine compared with tenofovir on adipocyte gene
expression, mitochondrial DNA copy number
and metabolic parameters in South African HIV-infected patients: a randomized
trial.
Menezes C, Duarte R, Dickens C, et al
HIV Med.
2012 Oct 4.
Abstract
FULL=TEXT ARTICLE
Stavudine Toxicity in Adult Longer-Term ART Patients in Blantyre, Malawi.
van Oosterhout JJ, Mallewa J, Kaunda S, et al
PLoS
One. 2012;7(7):e42029.
Paper
FULL-TEXT ARTICLE
Incidence of treatment-limiting toxicity with Stavudine-based
antiretroviral therapy in Cambodia:
a retrospective cohort study.
Phan V, Thai S, Choun K, et al
PLoS One.
2012;7(1):e30647
Paper |
A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT PDF
ARTICLE
A longitudinal study of stavudine-associated toxicities
in a large cohort of South African
HIV infected subjects.
Menezes CN, Maskew M, Sanne I, et al
BMC Infect Dis.
2011 Sep 17;11(1):244
Paper
Lactic acidosis associated with severe neuromuscular
weakness and stavudine therapy.
Vorasayan P, Phanthumchinda K.
J Med Assoc Thai. 2011
Apr;94(4):501-4.
Abstract
Stavudine Toxicity in Women Is the Main Reason for Treatment Change in
a
3-Year Prospective Cohort of Adult Patients Started on First-Line
Antiretroviral
Treatment in Uganda.
Castelnuovo B, Kiragga A, Kamya MR, Manabe Y.
J Acquir Immune Defic Syndr. 2010
Sep 21.
/b>
Abstract |
Stavudine- and nevirapine-related drug toxicity while on generic
fixed-dose antiretroviral
treatment: incidence, timing and risk factors in a three-year cohort
in Kigali, Rwanda.
van Griensven J, Zachariah R, Rasschaert F,
et al
Trans R Soc Trop Med Hyg.
2009 Sep 2
Abstract |
Effect of Reducing the Dose of Stavudine on Body Composition, Bone
Density, and Markers of
Mitochondrial Toxicity in HIV-Infected Subjects: A Randomized,
Controlled Study.
McComsey GA, Re Iii VL, O'Riordan M, et al
Clin Infect Dis. 2008 Apr 15;46(8):1290-1296
Abstract |
New questions about an old combination--ddI + d4T.
Proj Inf Perspect 2003 Jan;(35):13-4
Abstract |
|
|
|
Adherence, side effects and efficacy of stavudine plus lamivudine plus
nelfinavir in treatment-
experienced HIV-infected patients.
Roca B, Gomez CJ, Arnedo A
J Infect 2000 Jul;41(1):50-4
Abstract |
|